08:00 | Registration |
| Preclinical Drug Testing |
| |
09:00 | | Keynote Presentation Green Nanotechnology Approaches in Drug Discovery: Implications in Controlling Primary and Metastatic Tumours Kattesh V. Katti, Director, Institute of Green Nanotechnology / Radiology / Cancer Nanotechnology Platform, University of Missouri, United States of America
This presentation will discuss novel Green Nanotechnology approaches in drug discovery with direct implications in treating various forms of solid tumors. Development of Laminin receptor specific EGCg-AuNPs and their therapeutic efficacy in treating prostate tumors will be presented. The dual role of EGCG in offering target specificity and as an effective DNA methylation inhibitor will also be presented. |
|
09:30 | Developing New Models of University-Industry Collaborations for Commercialization of New Innovations Chris Fender, Director, University of Missouri, United States of America
This presentation will focus on new models for establishing collaborations between universities and industry for the successful commercialization of new biomedical innovations in an ever changing, global environment. |
10:00 | The Benefit of Companion Animal Models in Drug Development Carolyn Henry, Professor of Oncology, University of Missouri, United States of America
This session presented by a veterinary oncologist will illustrate how the use of companion animal models of spontaneously occurring disease can facilitate efficient preclinical assessment of novel drug therapies. |
10:30 | Coffee and Networking in Exhibiton Hall |
11:15 | Preclinical Models for Translational Research in Oncology and Allied Areas Ritu Verma, Head of Cell Biology, Dabur Research Foundation, India
This presentation will discuss the applications of in vitro, ex vivo & in vivo pre-clinical models for evaluation of new molecules for Oncology, Inflammation & Dermapathology. The delineation of molecular pathways operating in cancer & inflammation has enabled development of predictive preclinical models. Judicious selection & application of these disease models play a key role in evaluation of efficacy of new molecules & subsequent design of clinical trials. |
| Formulation and Solubility | Session Sponsors |
| |
11:45 | Copper–Promoted Carbon-Heteroatom Cross-coupling Reaction with Boronic Acids: A Powerful Synthetic Tool for Medicinal Chemist Parthasarathi Das, Scientist, Indian Institute of Integrative Medicine (CSIR), India
Recent development application of this methodology in synthesizing various heterocyclic with pharmaceutical interest will form the basic premise of my presentation. |
12:15 | Lunch and Networking in Exhibition Hall |
13:30 | Poster Viewing Session |
14:15 | Site-Selective Delivery of Nitric Oxide (NO) Harinath Chakrapani, Assistant Professor, Indian Institute of Science Education and Research, India
Strategies towards site-directed delivery of nitric oxide through the use of prodrugs and delivery vehicles will be discussed. |
| High-Throughput Synthetic Chemistry |
| |
14:45 | | Keynote Presentation The Evolving Landscape of Drug Targets Haian Fu, Professor and Director, Emory University, United States of America
An overview of current drug targets and emerging target areas will be presented to highlight opportunities for new drug discovery and associated challenges, Target discovery opportunities at protein-protein interaction interfaces will be illustrated by our genomics-based research that aims to bridge the gap between extensive genomics data and therapeutic development. |
|
15:15 | Coffee and Networking in Exhibiton Hall |
16:00 | High-Throughput Microwave Chemistry in Silicon Carbide Microtiter Plates C. Oliver Kappe, Professor and Scientific Director, Center for Continuous Flow Synthesis and Processing, University of Graz, Austria
A high-throughput heating platform made out of strongly microwave absorbing silicon carbide (SiC) equipped with 20 cylindrical wells of appropriate dimensions to be fitted with standard HPLC/GC vials serving as reaction vessels is presented. Microwave heating allows rapid and homogeneous heating of the entire plate, with minimal deviations recorded at different positions of the plate or inside the vessels. Utilizing an additional aluminum top plate fixed with six stainless steel bolts the reaction platforms can be heated up to 250 °C and 20 bar applied pressure inside the HPLC/GC autosampler vials. Four SiC plates (80 reactions) can be processed simultaneously by using the corresponding rotor inside the multimode microwave cavity.1
A key advantage of using autosampler vials as reaction vessels is the possibility of direct reaction monitoring, eliminating a transfer step from the reaction vial to the autosampler vial. Apart from its use for the performance of parallel catalyst/solvent screenings and reaction optimization, the SiC blocks were utilized to synthesize whole libraries of chemical compounds within a single multimode microwave run. More related to analytical chemistry applications, the system has been utilized for GC derivatization reactions in forensic laboratories, the enzymatic hydrolysis of protein-bound selenium, for acid-mediated hydrolysis of proteins and peptides, in forced degradations studies involving active pharmaceutical ingredients, and for parallel low-volume sealed vessel microwave-assisted solvent extractions. |
16:30 | CANCELLED - Advancing Innovation and Convergence in Cancer Research Jerry Lee, Deputy Director, National Institutes of Health, United States of America
|
17:00 | Drinks Reception |